CARA PANAS: Open Payments
NPI 1538550686 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 17 payments from 10 companies in 2025. Trend: 2023 $1,278 · 2024 $967 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $114 |
| Lilly USA, LLC | 3 | $62 |
| Abbott Laboratories | 3 | $53 |
| Novo Nordisk Inc | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 2 | $7 |
Products named: WATCHMAN FLX, MOUNJARO, VIEWMATE, Wegovy, REXULTI, Rybelsus, Veozah, ENSITE PRECISION.
Industry payments across OK — which companies pay providers there.
